Advertisement
Home Blog Page 2563
For women with early-stage unilateral breast cancer treated with surgery

Contralateral Prophylactic Mastectomy Rates Up Nationwide

Increase seen in all states from 2004 to 2012, with greatest increases in five contiguous Midwest states
For patients undergoing percutaneous coronary intervention

Target-Vessel Failure Rate Similar for Scaffold, Stent in PCI

Increased two-year event rate of definite or probable device thrombosis for scaffold versus stent group
Enteral docosahexaenoic acid supplementation does not reduce the risk of bronchopulmonary dysplasia for infants born before 29 weeks of gestation

Enteral DHA Doesn’t Cut Preemie Bronchopulmonary Dysplasia Risk

Relative risk of physiological bronchopulmonary dysplasia up for infants born before 29 weeks
Hepatitis B and C could be eliminated as serious public health problems in the United States by 2030

Hep B, C Could Be Eliminated As Public Health Threats by 2030

Tools exist to prevent hepatitis B and C mortality, including vaccination and treatment
Patients with chronic tension-type headache have impairments in cognitive ability and dysfunction in the neuroendocrine state

Chronic Tension-Type Headache Tied to Cognitive Impairment

Impairment may result from neuroendocrine dysfunction
For patients with dementia

Proton Pump Inhibitor Use Ups Pneumonia Risk in Dementia

Independent risk factors for pneumonia include age, male gender, underlying cerebrovascular disease
Tooth loss is associated with increased risks of cardiovascular disease and death in older women

Gum Disease, Tooth Loss Tied to Higher Mortality in Older Women

While gum disease more prevalent, it was not tied to higher CVD-related events
Assessment of hand function is an important component in the clinical evaluation of patients with rheumatoid arthritis and systemic sclerosis

Doctors Should Evaluate Hand Function in RA, Systemic Sclerosis

Loss of hand function may negatively impact physical status and health-related QoL in systemic sclerosis
The intravenous drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis and relapsing forms of the disease

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

First drug sanctioned in United States for primary progressive multiple sclerosis
The causal links between Zika virus infection

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly